Paul Grayson

Paul Grayson is currently the President and CEO of Radionetics Oncology. Previously, he held leadership positions at various biotech companies including Tentarix Biotherapeutics, Inc., Bird Rock Bio, Inc., Fate Therapeutics Inc, Senomyx, Inc., and Aurora BioSciences, Inc. Paul also served as a Venture Partner at Versant Ventures. He holds an MBA from the University of California, Irvine and a BS in Biochemistry and Computer Science from UCLA.